Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 46: 119-122, 2000;
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (16)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aoshima, T.
Right arrow Articles by Niwa, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aoshima, T.
Right arrow Articles by Niwa, T.
(Clinical Chemistry. 2000;46:119-122.)
© 2000 American Association for Clinical Chemistry, Inc.


Technical Briefs

Rapid Detection of Deletion Mutations in Inherited Metabolic Diseases by Melting Curve Analysis with LightCycler

Tsutomu Aoshima1,a, Yoshitaka Sekido2, Takashi Miyazaki2, Mitsuharu Kajita1, Shunji Mimura1, Kazuyoshi Watanabe1, Kaoru Shimokata2 and Toshimitsu Niwa2

1 Department of Pediatrics, Nagoya University School of Medicine, 65 Tsuruma-Cho, Showa-ku, Nagoya 466-8550, Japan;
2 Department of Clinical Preventive Medicine, Nagoya University Daiko Medical Center, 1-1-20 Daiko-minami, Higashi-ku, Nagoya 461-0047, Japan;
a author for correspondence: fax 81-52-719-1132, e-mail taoshima{at}med.nagoya-u.ac.jp

Recently, non-gel electrophoresis-requiring, fluorophore probe-based rapid techniques have been introduced to detect known single-point mutations using the LightCyclerTM (Roche Molecular Biochemicals) (1)(2)(3)(4). This technique provides very rapid analytical time, real-time detection, and visualized images. Many inherited metabolic diseases are caused not only by single-point mutations but also by small deletion mutations. However, no studies have been reported on the detection of such deletion mutations using the LightCycler. Using melting curve analysis with the LightCycler, we have succeeded in rapidly detecting a 2-bp deletion mutation in genomic DNA of a patient with Fabry disease and a 9-bp deletion mutation in cDNA of a patient with carbamoyl-phosphate synthase I (CPS1; EC 6.3.4.16) deficiency.

Fabry disease is an X-linked recessive disorder caused by the deficient activity of {alpha}-galactosidase ({alpha}-Gal; EC 3.2.1.22). A 15-year-old boy with classical Fabry disease who had suffered from angiokeratoma, acroparesthesias, and attacks of pain in his legs was referred to us. We extracted total RNA from his peripheral blood lymphocytes and analyzed the {alpha}-GAL gene (GLA; GenBank accession no. X14448) by reverse transcription-PCR (5). We sequenced a 1.3-kb PCR product covering the entire coding region and found a 2-bp deletion mutation at nucleotides 11 008–11 009. This change caused a frameshift mutation that had been described previously in another case of the disease (6).

With written informed consent, we examined the patient’s relatives, including his mother, his unaffected brother, and his maternal grandmother, to determine whether they carry this mutation. Genomic DNAs were obtained from their peripheral blood lymphocytes, using QIAamp Blood Kit® (Qiagen) according to the manufacturer’s instructions.

For fluorescence PCR analysis, we prepared two PCR primers (2Del-S and 2Del-AS) and two fluorescence probes (2Del-F and 2Del-LC; Table 1 ).A 25mer oligonucleotide probe, 2Del-LC, synthesized by standard phosphoramidite chemistry, was labeled at the 5' end with LC Red 640 (Roche Molecular Biochemicals) fluorophore and modified at the 3' end by phosphorylation to avoid extension. Another 20mer oligonucleotide probe, 2Del-F, was synthesized to anneal the region that contained the 2-bp deletion mutation inside, and was labeled at the 3' end with fluorescein. The distance between the two probes was 1 oligonucleotide. When both the probes hybridize in close proximity, fluorescence resonance energy transfer occurs, producing a specific fluorescence emission of LC-Red at 640 nm (Fig. 1 A).


View this table:
[in this window]
[in a new window]
 
Table 1. Oligonucleotides as PCR primers and hybridization probes.



View larger version (26K):
[in this window]
[in a new window]
 
Figure 1. Schematic illustration of PCR primers and fluorescence probes for {alpha}-GAL (A) and CPS1 (C) and derivative melting curves for genotyping of {alpha}-GAL (B) and CPS1 (D).

(A), fragment of {alpha}-GAL amplified by the two primers (2Del-S and 2Del-AS) is 186 bp in the wild type. When the fluorescence probes (2Del-F and 2Del-LC) hybridize in close proximity, fluorescence resonance energy transfer occurs, producing a specific fluorescence emission at 640 nm. In the mutated type, the two nucleotides of 2Del-F are surplus, forming a loop. , LC-Red; {circ}, fluorescein. (B), derivative melting curves for genotyping of {alpha}-GAL showed a single peak at high Tm in the wild type and a peak at low Tm in the mutated type. Whereas the curves of the unaffected brother (— — —) and maternal grandmother (- - - - - -) showed a wild-type pattern, the patient (————-) showed a hemizygous mutation pattern. The patient’s mother (— - — - —) showed a heterozygous pattern with two peaks. (C), fragment of CPS1 amplified by the two primers (9Del-S and 9Del-AS) is 55 bp in the wild type. When SYBR Green I dye binds to double-stranded DNA, it produces the specific fluorescence emission at 530 nm. {diamond}, SYBR Green I dye. (D), derivative melting curves for genotyping of CPS1 showed a single peak at high Tm in the wild type and a peak at low Tm in the mutated type. The patient with ornithine transcarbamoylase deficiency (— — —) showed a wild-type pattern, the plasmid (————-) showed a homozygous mutation pattern, and the patient with CPS1 deficiency (— - — - —) showed a heterozygous mutation pattern with two peaks.

The PCR reaction was performed in a 20-µL mixture containing 2 µL of LightCycler DNA Master Hybridization Probes (Taq DNA polymerase, reaction buffer, dNTP mixture, and 10 mmol/L MgCl2; Roche Molecular Biochemicals), 2.4 µL of 25 mmol/L MgCl2, 0.2 µmol/L each of the probes (2Del-F and 2Del-LC), 0.5 µmol/L each of the primers (2Del-S and 2Del-AS), and 50 ng of DNA. The amplified products were 186 bp in the wild type and 184 bp in the mutated type.

The thermal cycling was carried out as follows: initial denaturation at 95 °C for 30 s, followed by 50 cycles of denaturation at 95 °C for 0 s, annealing at 56 °C for 0 s, and extension at 72 °C for 4 s. The ramp rate was set at 20 °C/s. After amplification was complete, a melting curve in which fluorescence (F) was plotted against temperature (T), was obtained by holding at 95 °C for 30 s and then at 45 °C for 20 s, followed by heating slowly at 0.2 °C/s to 85 °C with continuous collection of fluorescence at 640 nm. It took ~30 min for this thermal cycling. The negative derivative of the fluorescence with respect to temperature (-dF/dT) was plotted against temperature.

Derivative melting curves demonstrated a clear difference between their genotypes (Fig. 1BUp ). The curves of the unaffected brother and maternal grandmother showed a wild-type pattern with peaks at 65.5 and 64.7 °C, respectively. On the other hand, because the 2-bp internal deletion decreased the melting temperature (Tm), the patient with Fabry disease showed a single peak at 60.3 °C, which is ~5 °C lower than the peaks in the wild type, demonstrating that he had the hemizygous mutation of the {alpha}-GAL gene. His mother showed a heterozygous pattern with two peaks at 59.9 and 65.7 °C, demonstrating that she was a carrier of the disease.

CPS1 deficiency is an autosomal recessive disorder caused by the deficient activity of CPS1, affecting the first enzyme step in the urea cycle. We investigated a boy with the neonatal type of the disease, who showed a low activity of CPS1 in the liver and died at age 28 because of severe hyperammonemia. After extracting total RNA from the liver at autopsy, we analyzed the CPS1 gene (GenBank accession no. Y15793) by reverse transcription-PCR. We synthesized 10 pairs of primer sets to cover the entire coding region (4.5 kb) and performed heteroduplex analysis with MDETM gel (FMC). The aberrant bands were subcloned into pGEM-T easy plasmid (Promega) and sequenced. Because a 9-bp in-frame deletion from nucleotide 832 to nucleotide 840 was identified in the cDNA, we amplified a genomic DNA fragment and found a G-to-C transition at nucleotide 840. Thus, we showed that this splicing abnormality was attributable to a point mutation located at the end of an exon-intron boundary at the donor site; the same mutation had been reported previously (7). Because we also detected a novel nucleotide substitution on the other allele (Aoshima et al., in preparation), he was shown to be a compound heterozygote with two point mutations.

SYBRTM Green I dye is a DNA double-strand-specific dye, and its fluorescence emission at 530 nm is greatly enhanced by its binding to double-stranded DNA (Fig. 1CUp ). Using this dye, we tested whether products that differ in Tm caused by a deletion can be identified. For fluorescence PCR analysis of the 9-bp deletion, we prepared two PCR primers (9Del-AS and 9Del-AS; Table 1Up ), and three templates; two were the reverse transcription products of the total RNA isolated from the liver of a patient with CPS1 deficiency and a patient with ornithine transcarbamoylase deficiency (as a control); a plasmid containing the homozygous 9-bp deletion mutation was used. The PCR was performed in a 20-µL mixture containing 2 µL of LightCycler DNA Master SYBR Green (Taq DNA polymerase, reaction buffer, dNTP mixture, SYBR Green I dye, and 10 mmol/L MgCl2; Roche Molecular Biochemicals), 2.4 µL of 25 mmol/L MgCl2, 0.5 µmol/L each of the primers (9Del-AS and 9Del-AS), and 50 ng of the templates. The amplified products were 55 bp in the wild type and 46 bp in the mutated type. The thermal cycling was carried out under the above conditions except that the extension was at 72 °C for 1 s and the fluorescence was monitored at 530 nm.

Derivative melting curves demonstrated a clear difference between the genotypes (Fig. 1DUp ). The curve of the control showed a wild-type pattern with a single peak at 76.6 °C. On the other hand, because the 9-bp internal deletion decreased its Tm, the plasmid containing the homozygous mutation showed a single peak at 74.9 °C, 1.8 °C lower than the wild type. The patient with CPS1 deficiency showed a heterozygous pattern with two peaks at 74.9 and 76.6 °C.

In this study, we first demonstrated that deletions of small nucleotides can be detected rapidly and easily by fluorophore techniques. We could distinguish the genotypes in a family of Fabry disease. The probe, 2Del-F, which contains the deletion site, hybridized to the mutation template, probably forming a loop with the surplus nucleotides. Therefore, it melted off from the mutation template at a lower temperature than from the wild-type template. This technique can be applied to cases with deletion mutations of larger numbers of nucleotides. The Tm of a PCR product depends on the length itself and GC content. If the difference between the Tms of the PCR products are large, they can be distinguished from each other using only SYBR Green I dye, as shown in the detection of the 9-bp deletion in CPS1 deficiency. This is a very simple procedure that does not require the designing of specific hybridization probes. However, the deletion must be enough large compared with the whole fragment or contain a high GC content to influence the Tm. For example, in the case of this 9-bp deletion, if the PCR products are 100 bp, the difference of Tm between the mutation and the wild type will be 0.6 °C, which is not detectable. Although the two mutations in this study are not common, we believe that this technique can be widely utilized for rapid and facile screening of the other diseases that have common deletion mutations.


References

  1. Lay MJ, Wittwer CT. Real-time fluorescence genotyping of factor V Leiden during rapid-cycle PCR. Clin Chem 1997;43:2262-2267. [Abstract/Free Full Text]
  2. Bernard PS, Lay MJ, Wittwer CT. Integrated amplification and detection of the C677T point mutation in the methylenetetrahydrofolate reductase gene by fluorescence resonance energy transfer and probe melting curves. Anal Biochem 1998;255:101-107. [Web of Science][Medline] [Order article via Infotrieve]
  3. Kyger EM, Krevolin MD, Powell MJ. Detection of the hereditary hemochromatosis gene mutation by real-time fluorescence polymerase chain reaction and peptide nucleic acid clamping. Anal Biochem 1988;260:142-148.
  4. von Ahsen N, Schutz E, Armstrong VW, Oellerich M. Rapid detection of prothrombotic mutations of prothrombin (G20210A), factor V (G1691A), and methylenetetrahydrofolate reductase (C677T) by real-time fluorescence PCR with the LightCycler. Clin Chem 1999;45:694-696. [Free Full Text]
  5. Miyazaki T, Kajita M, Ohmori S, Mizutani N, Niwa T, Murata Y, et al. A novel mutation (E358K) in the {alpha}-galactosidase A gene detected in a Japanese family with Fabry disease. Hum Mutat 1998;Suppl 1:S139–40..
  6. Germain D, Biasotto M, Tosi M, Meo T, Kahn A, Poenaru L. Fluorescence-assisted mismatch analysis (FAMA) for exhaustive screening of the {alpha}-galactosidase A gene and detection of carriers in Fabry disease. Hum Genet 1996;98:719-726. [Medline] [Order article via Infotrieve]
  7. Hoshide R, Matsuura T, Haraguchi Y, Endo F, Yoshinaga M, Matsuda I. Carbamyl phosphate synthase I deficiency. One base substitution in an exon of the CPSI gene causes a 9-basepair deletion due to aberrant splicing. J Clin Investig 1993;91:1884-1887.



The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
E. Rossou, A. Kouvatsi, C. Aslanidis, and C. Deltas
Multiplex Molecular Diagnosis of MEFV Mutations in Patients with Familial Mediterranean Fever by LightCycler Real-Time PCR
Clin. Chem., September 1, 2005; 51(9): 1725 - 1727.
[Full Text] [PDF]


Home page
Nucleic Acids ResHome page
G. Pont-Kingdon and E. Lyon
Direct molecular haplotyping by melting curve analysis of hybridization probes: beta 2-adrenergic receptor haplotypes as an example
Nucleic Acids Res., June 3, 2005; 33(10): e89 - e89.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. N. Gundry, J. G. Vandersteen, G. H. Reed, R. J. Pryor, J. Chen, and C. T. Wittwer
Amplicon Melting Analysis with Labeled Primers: A Closed-Tube Method for Differentiating Homozygotes and Heterozygotes
Clin. Chem., March 1, 2003; 49(3): 396 - 406.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
N. von Ahsen, M. Oellerich, and E. Schutz
Limitations of Genotyping Based on Amplicon Melting Temperature
Clin. Chem., July 1, 2001; 47(7): 1331 - 1332.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
R. H. Lipsky, C. M. Mazzanti, J. G. Rudolph, K. Xu, G. Vyas, D. Bozak, M. Q. Radel, and D. Goldman
DNA Melting Analysis for Detection of Single Nucleotide Polymorphisms
Clin. Chem., April 1, 2001; 47(4): 635 - 644.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
N. von Ahsen, M. Oellerich, and E. Schutz
DNA Base Bulge vs Unmatched End Formation in Probe-based Diagnostic Insertion/Deletion Genotyping: Genotyping the UGT1A1 (TA)n Polymorphism by Real-Time Fluorescence PCR
Clin. Chem., December 1, 2000; 46(12): 1939 - 1945.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (16)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aoshima, T.
Right arrow Articles by Niwa, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aoshima, T.
Right arrow Articles by Niwa, T.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS